Effectiveness of Moxibustion Treatment in Quality of Life in Patients with Knee Osteoarthritis: A Randomized, Double-Blinded, Placebo-Controlled Trial

Table 2

Comparison of SF-36 scores (mean ± SD).

8 dimensions of SF-36	Time points	True moxibustion group	Sham moxibustion group	value
PF	Baseline			0.428
	Week 3			0.661
	Week 6			0.467
	Week 12			0.871
RP	Baseline			0.177
	Week 3			0.894
	Week 6			0.811
	Week 12			0.678
RE	Baseline			0.381
	Week 3			0.871
	Week 6			0.342
	Week 12			0.465
VT	Baseline			0.858
	Week 3			0.791
	Week 6			0.265
	Week 12			0.042^d
MH	Baseline			0.289
	Week 3			0.214
	Week 6			0.435
	Week 12			0.366
SF	Baseline			0.236
	Week 3			0.536
	Week 6			0.799
	Week 12			0.600
BP	Baseline			0.751
	Week 3			0.434
	Week 6			0.506
	Week 12			0.723
GH	Baseline			0.390
	Week 3			0.360
	Week 6			0.015^d
	Week 12			0.029^d

BP: bodily pain; GH: general health; MH: mental health; RE: emotional role functionality; PF: physical functioning; RP: physical role functionality; SF: social role functionality; VT: vitality.
^aCompared with pretreatment: ; ^bcompared with pretreatment: ; ^ccompared with pretreatment: ; ^db-group comparison: .